Chimera Polymerase for Single-Enzyme RT-PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid amplification methods, particularly reverse transcription polymerase chain reaction (RT-PCR), face limitations in sensitivity, specificity, enzyme stability, inhibitor tolerance, and time to result due to the reliance on multiple enzymes, which leads to suboptimal reaction conditions and interference between enzymes.
Innovation Solution
Development of novel engineered polypeptides with altered amino acid sequences that combine reverse transcriptase and DNA polymerase activities, allowing for single enzyme RT-PCR reactions with improved thermostability and inhibitor tolerance, enabling efficient RNA amplification without the need for manganese.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If two distinct enzymes (reverse transcriptase and DNA polymerase) are used in RT-PCR, then reverse transcription and DNA amplification can be performed, but reaction conditions become a compromise between optimal conditions for each enzyme, reducing sensitivity and specificity
Solution Approach 1:
The patent merges reverse transcriptase and DNA polymerase activities into a single engineered polypeptide. The chimera polymerase contains both RT and DNA pol functional domains, allowing one enzyme to perform both reverse transcription and DNA amplification functions that previously required two separate enzymes, thereby eliminating compromise in reaction conditions
Solution Approach 2:
The engineered chimera polymerase is designed with multi-functionality, enabling a single enzyme to catalyze both reverse transcription of RNA to cDNA and subsequent DNA amplification reactions. This universal enzyme eliminates the need for separate RT and DNA pol enzymes, optimizing reaction conditions for both functions simultaneously
2Temperature
If retroviral reverse transcriptase is used for RT-PCR, then RNA template conversion to cDNA is achieved, but the enzyme lacks sufficient thermostability for PCR amplification at high temperatures
Solution Approach 1:
The patent creates a composite enzyme structure by fusing retroviral RT domain with thermostable DNA polymerase domain (such as Taq polymerase). This chimeric construction combines the RNA template recognition and reverse transcription capability of retroviral RT with the high thermostability of bacterial DNA polymerase, enabling the enzyme to function at PCR temperatures
Solution Approach 2:
The patent modifies enzyme parameters through genetic engineering to achieve desired properties. The chimera polymerase construction changes the thermal stability parameter of the reverse transcriptase component by combining it with thermostable DNA pol domains, while maintaining the catalytic functionality for RNA-dependent DNA synthesis through domain fusion
3Adaptability or versatility
If manganese is added to enable thermostable DNA polymerase to function as reverse transcriptase, then RT activity is achieved, but the reaction requires non-standard buffer conditions and may reduce fidelity
Solution Approach 1:
Instead of modifying buffer conditions (adding manganese) to enable DNA polymerase to perform reverse transcription, the patent inverts the approach by engineering the enzyme itself to possess inherent RT activity. The chimera polymerase is genetically constructed with RT domain fused to DNA pol domain, allowing it to perform reverse transcription using standard magnesium-containing buffers without requiring manganese addition
4Productivity
If multiple enzymes are present in a single tube for RT-PCR, then both reverse transcription and amplification can occur, but direct interference between enzymes may limit sensitivity
Solution Approach 1:
The patent eliminates enzyme interference by merging RT and DNA polymerase functions into a single chimera polypeptide. This monoenzyme system performs both reverse transcription and DNA amplification without the cross-interference that occurs when multiple separate enzymes are present in the same reaction tube, thereby maintaining amplification efficiency while avoiding inhibitory interactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered polypeptides enhance the sensitivity and specificity of RNA detection, improve enzyme stability, and reduce the time to result, while maintaining high fidelity and accuracy in cDNA synthesis, even in the presence of inhibitors, thus overcoming the limitations of traditional two-enzyme systems.
Implementation Method 1
a thermolabile reverse transcriptase (RT), often a murine Moloney leukemia virus (MMLV) RT derivative, that synthesizes complementary DNA (cDNA) based on an RNA template
Implementation Method 2
a distinct DNA polymerase, commonly Taq polymerase, for amplification of the DNA product
Implementation Method 3
novel engineered polypeptides with altered amino acid sequences that combine reverse transcriptase and DNA polymerase activities, allowing for single enzyme RT-PCR reactions with improved thermostability
Data Source
AI summary
The present invention provides novel engineered polypeptides that support both reverse transcription and DNA amplification in manganese-independent reactions. The present invention also provides methods for amplifying template nucleic acids using such polypeptides. This invention addresses deficiencies in the current state of the art in nucleic acid amplification-based detection of template nucleic acids, especially RNA targets, including deficiencies in detection sensitivity, specificity, enzyme stability, inhibitor tolerance and time to result compared with manganese-dependent thermostable reverse transcriptases and two-enzyme solutions.